CD44 and central nervous system cancer: Similarly, inhibiting highly expressed VEGFR1 on glioma-associated macrophages/microglia reduced glioblastoma angiogenesis and prolonged the survival of tumor-bearing mice [57], and high expression of SPP1-CD44 promoted macrophage infiltration, leading to poor prognosis [58].